Ładowanie...

Nektar, Cellular Biomedicine Enter New Clinical Study Collaboration

RTTNews | 263 dni temu

Nektar, Cellular Biomedicine Enter New Clinical Study Collaboration

(RTTNews) - Nektar Therapeutics (NKTR) announced Wednesday that it has entered into a new clinical study collaboration with Cellular Biomedicine Group Inc. (CBMG).

The study will evaluate Nektar's NKTR-255, a novel interleukin-15 (IL-15) receptor agonist, in combination with CBMG's C-TIL051, a tumor-infiltrating lymphocyte (TIL) therapy, in advanced non-small cell lung cancer (NSCLC) patients that are relapsed or refractory to anti-PD-1 therapy.

Preclinical and early clinical data suggest that IL-15 can improve proliferation and persistence of cellular therapies including TIL, TCR, and CAR-T therapies to increase specific anti-tumor activity.

Under the new collaboration, CBMG will add NKTR-255 to its ongoing CBMG-sponsored Phase 1 clinical trial evaluating C-TIL051 in NSCLC patients who have relapsed on or were refractory to anti-PD-1 therapy.

The study is expected to enroll a total of 20 patients. Nektar will contribute NKTR-255 supply for the study. Nektar and CBMG will each maintain existing global rights to their respective investigational medicines.

For More Such Health News, visit rttnews.com

Tagi: NKTR CBMG

read more

Nektar Therapeutics Promotes Chief Accounting Officer Jillian Thomsen To CFO

Nektar Therapeutics Promotes Chief Accounting Officer Jillian Thomsen To CFO

Nektar Therapeutics (NKTR) announced Friday the promotion of Jillian Thomsen to Senior Vice President (SVP) & Chief Financial Officer. Thomsen has served as SVP, Finance & Chief Accounting Officer of Nektar since 2008, and is a key member of the Executive Committee.

RTTNews | 716 dni temu

China Bourse Likely To Remain Rangebound

China Bourse Likely To Remain Rangebound

The China stock market has alternated between positive and negative finishes through the last five trading days since the end of the two-day slide in which it had fallen more than 40 points or 1.3 percent. The Shanghai Composite Index now rests just above the 3,030-point plateau and its tipped to open in the red again on Monday.

RTTNews | 4g 34 minut temu

Japan Core Machinery Orders Sink 2.9% In April

Japan Core Machinery Orders Sink 2.9% In April

The value of core machinery orders in Japan was down a seasonally adjusted 2.9 percent on month in April, the Cabinet Office said on Monday - coming in at 886.3 billion yen.

RTTNews | 4g 38 minut temu

New Zealand Services Index Slumps In May - BusinessNZ

New Zealand Services Index Slumps In May - BusinessNZ

The services sector in New Zealand continue to contract in May, and at a faster rate, the latest survey from BusinessNZ revealed on Monday with a Performance of Services Index score of 43.0.

RTTNews | 4g 47 minut temu

Taiwan Shares May Run Out Of Steam On Monday

Taiwan Shares May Run Out Of Steam On Monday

The Taiwan stock market has finished higher in three straight sessions, rallying more than 700 points or 3.3 percent along the way. The Taiwan Stock Exchange now sits just above the 22,500-point plateau although the rally may stall on Monday.

RTTNews | 5g 4 minut temu

KOSPI Due For Profit Taking On Monday

KOSPI Due For Profit Taking On Monday

The South Korea stock market has climbed higher in four straight sessions, advancing more than 55 points or 2 percent in that span. The KOSPI now rests just shy of the 2,760-point plateau although investors may lock in gains on Monday.

RTTNews | 5g 34 minut temu

China Data Due On Monday

China Data Due On Monday

China is scheduled to release a raft of data on Monday, headlining an otherwise light day for Asia-Pacific economic activity. On tap are May figures for house prices, fixed asset investment, industrial production, retail sales and unemployment.

RTTNews | 6g 34 minut temu

TSX Ends Lower Again, Sheds About 1.7% In Week

TSX Ends Lower Again, Sheds About 1.7% In Week

Despite recovering from early lows, the Canadian market ended weak on Friday, hurt by losses in consumer staples and communications sectors.

RTTNews | 2 dni temu

Warunki | Prywatność | Mapa serwisu | Site Map Calendar

© 2024 Myfxbook Ltd. Wszelkie Prawa Zastrzeżone.

Ostrzeżenie o wysokim ryzyku: handel walutami obcymi wiąże się z wysokim poziomem ryzyka, który może nie być odpowiedni dla wszystkich inwestorów. Dźwignia stwarza dodatkowe ryzyko i ryzyko straty. Zanim zdecydujesz się na handel walutami, dokładnie przemyśl swoje cele inwestycyjne, poziom doświadczenia i tolerancję ryzyka. Możesz stracić część lub całość początkowej inwestycji. Nie inwestuj pieniędzy, których nie możesz stracić. Zbadaj ryzyko związane z handlem walutami i zasięgnij porady niezależnego doradcy finansowego lub podatkowego, jeśli masz jakiekolwiek pytania. Wszelkie dane i informacje są dostarczane "tak, jak są" wyłącznie w celach informacyjnych i nie są przeznaczone do celów handlowych ani konsultacji. Wcześniejsze wyniki nie są wskaźnikiem przyszłych wyników.